Schedule 13G ownership disclosure

PLX PHARMA INC. XXXBANKRUPTCY EFF: 10/02/23

Security class unavailable · CUSIP: 72942A107

Event date: 2020-11-16

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
970,425
Percent of class
6.7000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001019056-20-000644
Form type
SC 13G
Filer
PLx Pharma Inc.
CIK
CIK 1497504
Filed
Dec 18, 2020
Reporting period
Nov 16, 2020
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub